DelveInsight has launched a new report on “Postoperative Pain – Market Insights, Epidemiology, and Market Forecast-2032”.
DelveInsight’s “Postoperative Pain – Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Postoperative Pain, historical and forecasted epidemiology as well as the Postoperative Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Postoperative Pain Market Report:
1. As per our analysis, the total number of cases in 2020 of postoperative pain in the 7MM was ~66,426,000 which is expected to increase at a significant rate.
2. In 2020, the total number of patients with postoperative pain in the US was ~40,618,000. The majority of the cases were of moderated type (44.50%).
4. In EU5, the number of cases was highest in Germany followed by France and the United Kingdom while the least number of cases were reported in Spain during the study period (2019–2032).
5. In 2020, Japan reported 1,22,49,558 cases of Postoperative pain, out of which there were ~54,51,000 cases of moderate type.
6. As per DelveInsight’s assessment, globally, about 45+ key pharma and biotech companies are working on 50+ pipeline drugs in the Postoperative Pain therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
Key benefits of the Postoperative Pain market report:
1. Postoperative Pain market report covers a descriptive overview and comprehensive insight of the Postoperative Pain Epidemiology and Postoperative Pain market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Postoperative Pain market report provides insights on the current and emerging therapies.
3. Postoperative Pain market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Postoperative Pain market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Postoperative Pain market.
Got queries? Click here to know more about the Postoperative Pain Market Landscape.
Postoperative Pain Overview
Postoperative pain refers to the discomfort or pain experienced by individuals following a surgical procedure. It’s a common consequence of surgery and can vary in intensity depending on the type of surgery, individual pain tolerance, and other factors.
Several factors contribute to postoperative pain:
Surgical Procedure: The extent and complexity of the surgery play a significant role in determining the level of postoperative pain. More invasive procedures or surgeries involving larger incisions tend to result in more significant pain.
Individual Pain Sensitivity: Pain perception varies among individuals. Some people may experience more intense pain after surgery due to their sensitivity to pain.
Preexisting Conditions: People with preexisting chronic pain conditions may experience amplified postoperative pain due to heightened sensitivity.
Age: Younger and older individuals may have different pain experiences after surgery.
Medications and Anesthesia: The type of anesthesia used during the surgery and the pain management plan afterward can influence postoperative pain levels.
Managing postoperative pain is crucial for patient comfort and recovery. Treatments and strategies for controlling postoperative pain include:
Pain Medications: Analgesics, including opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen, are commonly used to manage postoperative pain. However, efforts are made to minimize opioid use due to their potential side effects and the risk of dependence.
Regional Anesthesia Techniques: Nerve blocks or epidural anesthesia may be used during surgery or in the postoperative period to minimize pain.
Multimodal Pain Management: A combination of medications and techniques is often employed to target pain from different angles, aiming to reduce reliance on opioids and minimize side effects.
Physical Therapy and Rehabilitation: Early mobilization, physical therapy, and exercises prescribed by healthcare professionals can aid in pain relief and recovery.
Patient Education: Providing information to patients about pain management strategies, setting realistic expectations, and addressing concerns can positively impact their postoperative pain experience.
Effective pain management after surgery involves a personalized approach tailored to the patient’s needs and the nature of the surgical procedure. Regular assessment and monitoring of pain levels are essential to adjust the treatment plan accordingly and ensure optimal comfort and recovery.
Postoperative Pain Market
The dynamics of the Postoperative Pain market are anticipated to change in the coming years owing to the expected launch of emerging therapies by key pharma players such as ACADIA Pharmaceuticals, Adynxx, Apsen Farmaceutica, Arthritis Innovation Corporation, Cali Pharmaceuticals, Charleston Laboratories, Concentric Analgesics, Cytogel, Flexion Therapeutics, Formosa Pharmaceuticals, Grünenthal, Haisco Pharmaceutical Group, Hefei Cosource Pharmaceutical, Jiangsu Hengrui Medicine, Layerbio, Mati Therapeutics, McNeil Consumer Pharmaceuticals, MedinCell, Mylan, Nang Kuang Pharmaceutical, Neumentum Pharmaceuticals, NeurOp, Nevakar, Novartis, Novartis Pharmaceuticals, Oculis Pharma, PainReform, Salvat, Salvat Laboratories, Shijiazhuang Yiling Pharmaceutical, SiteOne Therapeutics, Surface Ophthalmics, Taiwan Liposome Company, Teikoku Pharma USA, Trevena, Unither Pharmaceuticals, Vertex Pharmaceuticals, Vivozon, Xgene Pharmaceutical, and others during the forecasted period 2019-2032.
Postoperative Pain Pipeline Therapies and Key Companies
• ACP-044: ACADIA Pharmaceuticals
• CAM2048: Camurus
• CYT-1010: Cytogel Pharma
• DEXTENZA (dexamethasone): Ocular Therapeutix
• Qutenza: Grunenthal
• ST 2427: SiteOne Therapeutics
• SVT-15473 (clobetasol propionate ophthalmic nanoemulsion 0.05%): Salvat Laboratories
• TLC590: Taiwan Liposome Company
• VVZ-149: Vivozon
• ZYNRELEF (bupivacaine and meloxicam): Heron Therapeutics
To know more about the key postoperative pain pharma players in the market, visit postoperative pain therapeutics landscape.
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Postoperative Pain Patient Share (%) Overview at a Glance
5. Postoperative Pain Market Overview at a Glance
6. Postoperative Pain Disease Background and Overview
7. Postoperative Pain Epidemiology and Patient Population
8. Country-Specific Patient Population of Postoperative Pain
9. Postoperative Pain Current Treatment and Medical Practices
10. Unmet Needs
11. Postoperative Pain Emerging Therapies
12. Postoperative Pain Market Outlook
13. Country-Wise Postoperative Pain Market Analysis (2019–2032)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Postoperative Pain Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Postoperative Pain Market Outlook 2032.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services